HCPLive Network

Low-T

Do longer periods of androgen-deprivation therapy significantly improve prostate cancer survival rates or needlessly impair quality of life for recovering patients?
New research suggests that low testosterone levels may indicate that men face a greater risk of sudden cardiac arrest.
Stendra (avanafil) is now the only FDA-approved erectile dysfunction (ED) medication indicated to be taken as early as approximately 15 minutes before sexual activity.
Staff scientists at the US Food and Drug Administration (FDA) have concluded that there’s no “convincing evidence” linking testosterone replacement therapy with adverse cardiovascular events.
A new study showing significant negative correlation between phthalate absorption and testosterone levels adds considerably more weight and significant new details to a growing body of research.
There is little evidence that testosterone drugs are either beneficial or pose serious health risks to men, the U.S. Food and Drug Administration says in a review posted online Wednesday.
Low-T Upcoming Events
Low-T Latest News
Low-T Clinical Trials
Low-T Resources